Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 397

1.

Randomised controlled trial of adjunctive inspiratory muscle training for patients with COPD.

Charususin N, Gosselink R, Decramer M, Demeyer H, McConnell A, Saey D, Maltais F, Derom E, Vermeersch S, Heijdra YF, van Helvoort H, Garms L, Schneeberger T, Kenn K, Gloeckl R, Langer D.

Thorax. 2018 Oct;73(10):942-950. doi: 10.1136/thoraxjnl-2017-211417. Epub 2018 Jun 18.

PMID:
29914940
2.

Teamwork and Adherence to Recommendations Explain the Effect of a Care Pathway on Reduced 30-day Readmission for Patients with a COPD Exacerbation.

Seys D, Bruyneel L, Sermeus W, Lodewijckx C, Decramer M, Deneckere S, Panella M, Vanhaecht K.

COPD. 2018 Apr;15(2):157-164. doi: 10.1080/15412555.2018.1434137. Epub 2018 Feb 20.

PMID:
29461135
3.

A simple algorithm for the identification of clinical COPD phenotypes.

Burgel PR, Paillasseur JL, Janssens W, Piquet J, Ter Riet G, Garcia-Aymerich J, Cosio B, Bakke P, Puhan MA, Langhammer A, Alfageme I, Almagro P, Ancochea J, Celli BR, Casanova C, de-Torres JP, Decramer M, Echazarreta A, Esteban C, Gomez Punter RM, Han MK, Johannessen A, Kaiser B, Lamprecht B, Lange P, Leivseth L, Marin JM, Martin F, Martinez-Camblor P, Miravitlles M, Oga T, Sofia Ramírez A, Sin DD, Sobradillo P, Soler-Cataluña JJ, Turner AM, Verdu Rivera FJ, Soriano JB, Roche N; Initiatives BPCO, EABPCO, Leuven and 3CIA study groups.

Eur Respir J. 2017 Nov 2;50(5). pii: 1701034. doi: 10.1183/13993003.01034-2017. Print 2017 Nov.

4.

Respiratory muscle function and exercise limitation in patients with chronic obstructive pulmonary disease: a review.

Charususin N, Dacha S, Gosselink R, Decramer M, Von Leupoldt A, Reijnders T, Louvaris Z, Langer D.

Expert Rev Respir Med. 2018 Jan;12(1):67-79. doi: 10.1080/17476348.2018.1398084. Epub 2017 Nov 6. Review.

PMID:
29072087
5.

Erratum to "Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report: GOLD Executive Summary" [Arch Bronconeumol. 2017;53:128-49].

Vogelmeier CF, Criner GJ, Martínez FJ, Anzueto A, Barnes PJ, Bourbeau J, Celli BR, Chen R, Decramer M, Fabbri LM, Frith P, Halpin DMG, Varela MVL, Nishimura M, Roche N, Rodríguez-Roisin R, Sin DD, Singh D, Stockley R, Vestbo J, Wedzicha JA, Agustí A.

Arch Bronconeumol. 2017 Jul;53(7):411-412. doi: 10.1016/j.arbres.2017.06.001. English, Spanish. No abstract available.

6.

Cardiovascular Disease Does Not Predict Exacerbation Rate or Mortality in Chronic Obstructive Pulmonary Disease.

Jones PW, Mullerova H, Agusti A, Decramer M, Adamek L, Raillard A, Zhu CQ, Wedzicha JA.

Am J Respir Crit Care Med. 2018 Feb 1;197(3):400-403. doi: 10.1164/rccm.201706-1066LE. No abstract available.

7.

Effect of a single exacerbation on decline in lung function in COPD.

Halpin DMG, Decramer M, Celli BR, Mueller A, Metzdorf N, Tashkin DP.

Respir Med. 2017 Jul;128:85-91. doi: 10.1016/j.rmed.2017.04.013. Epub 2017 Apr 24.

8.

Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report: GOLD Executive Summary.

Vogelmeier CF, Criner GJ, Martínez FJ, Anzueto A, Barnes PJ, Bourbeau J, Celli BR, Chen R, Decramer M, Fabbri LM, Frith P, Halpin DM, López Varela MV, Nishimura M, Roche N, Rodríguez-Roisin R, Sin DD, Singh D, Stockley R, Vestbo J, Wedzicha JA, Agustí A.

Arch Bronconeumol. 2017 Mar;53(3):128-149. doi: 10.1016/j.arbres.2017.02.001. Epub 2017 Mar 6. English, Spanish. Erratum in: Arch Bronconeumol. 2017 Jul;53(7):411-412.

9.

Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report: GOLD Executive Summary.

Vogelmeier CF, Criner GJ, Martinez FJ, Anzueto A, Barnes PJ, Bourbeau J, Celli BR, Chen R, Decramer M, Fabbri LM, Frith P, Halpin DM, López Varela MV, Nishimura M, Roche N, Rodriguez-Roisin R, Sin DD, Singh D, Stockley R, Vestbo J, Wedzicha JA, Agusti A.

Eur Respir J. 2017 Mar 6;49(3). pii: 1700214. doi: 10.1183/13993003.00214-2017. Print 2017 Mar. Erratum in: Eur Respir J. 2017 Jun 22;49(6):.

10.

Global Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Lung Disease 2017 Report: GOLD Executive Summary.

Vogelmeier CF, Criner GJ, Martinez FJ, Anzueto A, Barnes PJ, Bourbeau J, Celli BR, Chen R, Decramer M, Fabbri LM, Frith P, Halpin DM, López Varela MV, Nishimura M, Roche N, Rodriguez-Roisin R, Sin DD, Singh D, Stockley R, Vestbo J, Wedzicha JA, Agusti A.

Respirology. 2017 Apr;22(3):575-601. doi: 10.1111/resp.13012. Epub 2017 Mar 7.

11.

Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report. GOLD Executive Summary.

Vogelmeier CF, Criner GJ, Martinez FJ, Anzueto A, Barnes PJ, Bourbeau J, Celli BR, Chen R, Decramer M, Fabbri LM, Frith P, Halpin DM, López Varela MV, Nishimura M, Roche N, Rodriguez-Roisin R, Sin DD, Singh D, Stockley R, Vestbo J, Wedzicha JA, Agustí A.

Am J Respir Crit Care Med. 2017 Mar 1;195(5):557-582. doi: 10.1164/rccm.201701-0218PP.

12.

Automated Interpretation of Pulmonary Function Tests in Adults with Respiratory Complaints.

Topalovic M, Laval S, Aerts JM, Troosters T, Decramer M, Janssens W; Belgian Pulmonary Function Study investigators.

Respiration. 2017;93(3):170-178. doi: 10.1159/000454956. Epub 2017 Jan 12.

13.

An International Study of Adherence to Guidelines for Patients Hospitalised with a COPD Exacerbation.

Seys D, Bruyneel L, Decramer M, Lodewijckx C, Panella M, Sermeus W, Boto P, Vanhaecht K.

COPD. 2017 Apr;14(2):156-163. doi: 10.1080/15412555.2016.1257599. Epub 2016 Dec 20.

PMID:
27997254
14.

Impact of a care pathway for COPD on adherence to guidelines and hospital readmission: a cluster randomized trial.

Vanhaecht K, Lodewijckx C, Sermeus W, Decramer M, Deneckere S, Leigheb F, Boto P, Kul S, Seys D, Panella M.

Int J Chron Obstruct Pulmon Dis. 2016 Nov 23;11:2897-2908. eCollection 2016.

15.

Survival after pulmonary rehabilitation in patients with COPD: impact of functional exercise capacity and its changes.

Camillo CA, Langer D, Osadnik CR, Pancini L, Demeyer H, Burtin C, Gosselink R, Decramer M, Janssens W, Troosters T.

Int J Chron Obstruct Pulmon Dis. 2016 Oct 26;11:2671-2679. eCollection 2016.

16.

Evaluation of the effects of olodaterol on exercise endurance in patients with chronic obstructive pulmonary disease: results from two 6-week crossover studies.

Maltais F, Kirsten AM, Hamilton A, De Sousa D, Voß F, Decramer M.

Respir Res. 2016 Jul 6;17(1):77. doi: 10.1186/s12931-016-0389-5.

17.

Defining a COPD composite safety endpoint for demonstrating efficacy in clinical trials: results from the randomized, placebo-controlled UPLIFT® trial.

Celli BR, Decramer M, Liu D, Metzdorf N, Asijee GM, Tashkin DP.

Respir Res. 2016 May 4;17(1):48. doi: 10.1186/s12931-016-0361-4.

18.

Inspiratory muscle training improves breathing pattern during exercise in COPD patients.

Charususin N, Gosselink R, McConnell A, Demeyer H, Topalovic M, Decramer M, Langer D.

Eur Respir J. 2016 Apr;47(4):1261-4. doi: 10.1183/13993003.01574-2015. Epub 2016 Feb 25. No abstract available.

19.

Correction: Physical Activity Counselling during Pulmonary Rehabilitation in Patients with COPD: A Randomised Controlled Trial.

Burtin C, Langer D, van Remoortel H, Demeyer H, Gosselink R, Decramer M, Dobbels F, Janssens W, Troosters T.

PLoS One. 2016 Feb 1;11(2):e0148705. doi: 10.1371/journal.pone.0148705. eCollection 2016. No abstract available.

20.

Physical Activity Counselling during Pulmonary Rehabilitation in Patients with COPD: A Randomised Controlled Trial.

Burtin C, Langer D, van Remoortel H, Demeyer H, Gosselink R, Decramer M, Dobbels F, Janssens W, Troosters T.

PLoS One. 2015 Dec 23;10(12):e0144989. doi: 10.1371/journal.pone.0144989. eCollection 2015. Erratum in: PLoS One. 2016;11(2):e0148705.

21.

Morphometric Analysis of Explant Lungs in Cystic Fibrosis.

Boon M, Verleden SE, Bosch B, Lammertyn EJ, McDonough JE, Mai C, Verschakelen J, Kemner-van de Corput M, Tiddens HA, Proesmans M, Vermeulen FL, Verbeken EK, Cooper J, Van Raemdonck DE, Decramer M, Verleden GM, Hogg JC, Dupont LJ, Vanaudenaerde BM, De Boeck K.

Am J Respir Crit Care Med. 2016 Mar 1;193(5):516-26. doi: 10.1164/rccm.201507-1281OC.

PMID:
26551917
22.

Toward antiviral therapy/prophylaxis for rhinovirus-induced exacerbations of chronic obstructive pulmonary disease: challenges, opportunities, and strategies.

Thibaut HJ, Lacroix C, De Palma AM, Franco D, Decramer M, Neyts J.

Rev Med Virol. 2016 Jan;26(1):21-33. doi: 10.1002/rmv.1856. Epub 2015 Sep 21. Review.

PMID:
26388447
23.

DNA methylation profiling of non-small cell lung cancer reveals a COPD-driven immune-related signature.

Wauters E, Janssens W, Vansteenkiste J, Decaluwé H, Heulens N, Thienpont B, Zhao H, Smeets D, Sagaert X, Coolen J, Decramer M, Liston A, De Leyn P, Moisse M, Lambrechts D.

Thorax. 2015 Dec;70(12):1113-22. doi: 10.1136/thoraxjnl-2015-207288. Epub 2015 Sep 8.

PMID:
26349763
24.

Safety of inhaled glycopyrronium in patients with COPD: a comprehensive analysis of clinical studies and post-marketing data.

D'Urzo AD, Kerwin EM, Chapman KR, Decramer M, DiGiovanni R, D'Andrea P, Hu H, Goyal P, Altman P.

Int J Chron Obstruct Pulmon Dis. 2015 Aug 11;10:1599-612. doi: 10.2147/COPD.S81266. eCollection 2015.

25.

Airways resistance and specific conductance for the diagnosis of obstructive airways diseases.

Topalovic M, Derom E, Osadnik CR, Troosters T, Decramer M, Janssens W; Belgian Pulmonary Function Study Investigators.

Respir Res. 2015 Jul 22;16:88. doi: 10.1186/s12931-015-0252-0.

26.

Effect of Tiotropium on Outcomes in Patients With COPD, Categorized Using the New GOLD Grading System: Results of the UPLIFT® Randomized Controlled Trial.

Halpin DMG, Tashkin DP, Celli BR, Leimer I, Metzdorf N, Decramer M.

Chronic Obstr Pulm Dis. 2015 Jun 23;2(3):236-251. doi: 10.15326/jcopdf.2.3.2014.0142.

27.

Changes in GOLD: today and tomorrow.

Vogelmeier CF, Vestbo J, Hurd SS, Decramer M.

Lancet Respir Med. 2015 Jun;3(6):424-6. doi: 10.1016/S2213-2600(15)00191-5. No abstract available.

PMID:
26065970
28.

Cardiac safety of tiotropium in patients with cardiac events: a retrospective analysis of the UPLIFT® trial.

Tashkin DP, Leimer I, Metzdorf N, Decramer M.

Respir Res. 2015 Jun 2;16:65. doi: 10.1186/s12931-015-0216-4.

29.

An official American Thoracic Society/European Respiratory Society statement: research questions in COPD.

Celli BR, Decramer M, Wedzicha JA, Wilson KC, Agustí AA, Criner GJ, MacNee W, Make BJ, Rennard SI, Stockley RA, Vogelmeier C, Anzueto A, Au DH, Barnes PJ, Burgel PR, Calverley PM, Casanova C, Clini EM, Cooper CB, Coxson HO, Dusser DJ, Fabbri LM, Fahy B, Ferguson GT, Fisher A, Fletcher MJ, Hayot M, Hurst JR, Jones PW, Mahler DA, Maltais F, Mannino DM, Martinez FJ, Miravitlles M, Meek PM, Papi A, Rabe KF, Roche N, Sciurba FC, Sethi S, Siafakas N, Sin DD, Soriano JB, Stoller JK, Tashkin DP, Troosters T, Verleden GM, Verschakelen J, Vestbo J, Walsh JW, Washko GR, Wise RA, Wouters EF, ZuWallack RL; ATS/ERS Task Force for COPD Research.

Eur Respir Rev. 2015 Jun;24(136):159-72. doi: 10.1183/16000617.00000315. Review.

30.

Using dynamics of forced expiration to identify COPD where conventional criteria for the FEV₁ /FVC ratio do not match.

Topalovic M, Exadaktylos V, Decramer M, Berckmans D, Troosters T, Janssens W.

Respirology. 2015 Aug;20(6):925-31. doi: 10.1111/resp.12540. Epub 2015 Apr 16.

31.

Efficacy of a Novel Method for Inspiratory Muscle Training in People With Chronic Obstructive Pulmonary Disease.

Langer D, Charususin N, Jácome C, Hoffman M, McConnell A, Decramer M, Gosselink R.

Phys Ther. 2015 Sep;95(9):1264-73. doi: 10.2522/ptj.20140245. Epub 2015 Apr 9.

PMID:
25858974
32.

An Official American Thoracic Society/European Respiratory Society Statement: Research questions in chronic obstructive pulmonary disease.

Celli BR, Decramer M, Wedzicha JA, Wilson KC, Agustí A, Criner GJ, MacNee W, Make BJ, Rennard SI, Stockley RA, Vogelmeier C, Anzueto A, Au DH, Barnes PJ, Burgel PR, Calverley PM, Casanova C, Clini EM, Cooper CB, Coxson HO, Dusser DJ, Fabbri LM, Fahy B, Ferguson GT, Fisher A, Fletcher MJ, Hayot M, Hurst JR, Jones PW, Mahler DA, Maltais F, Mannino DM, Martinez FJ, Miravitlles M, Meek PM, Papi A, Rabe KF, Roche N, Sciurba FC, Sethi S, Siafakas N, Sin DD, Soriano JB, Stoller JK, Tashkin DP, Troosters T, Verleden GM, Verschakelen J, Vestbo J, Walsh JW, Washko GR, Wise RA, Wouters EF, ZuWallack RL; ATS/ERS Task Force for COPD Research.

Am J Respir Crit Care Med. 2015 Apr 1;191(7):e4-e27. doi: 10.1164/rccm.201501-0044ST.

PMID:
25830527
33.

An official American Thoracic Society/European Respiratory Society statement: research questions in COPD.

Celli BR, Decramer M, Wedzicha JA, Wilson KC, Agustí A, Criner GJ, MacNee W, Make BJ, Rennard SI, Stockley RA, Vogelmeier C, Anzueto A, Au DH, Barnes PJ, Burgel PR, Calverley PM, Casanova C, Clini EM, Cooper CB, Coxson HO, Dusser DJ, Fabbri LM, Fahy B, Ferguson GT, Fisher A, Fletcher MJ, Hayot M, Hurst JR, Jones PW, Mahler DA, Maltais F, Mannino DM, Martinez FJ, Miravitlles M, Meek PM, Papi A, Rabe KF, Roche N, Sciurba FC, Sethi S, Siafakas N, Sin DD, Soriano JB, Stoller JK, Tashkin DP, Troosters T, Verleden GM, Verschakelen J, Vestbo J, Walsh JW, Washko GR, Wise RA, Wouters EF, ZuWallack RL; ATS/ERS Task Force for COPD Research.

Eur Respir J. 2015 Apr;45(4):879-905. doi: 10.1183/09031936.00009015. Review.

34.

Effects of Tiotropium on Exacerbations in Patients with COPD with Low or High Risk of Exacerbations: A Post-Hoc Analysis from the 4-Year UPLIFT® Trial.

Celli BR, Decramer M, Asijee GM, Kupas K, Tashkin DP.

Chronic Obstr Pulm Dis. 2015 Mar 27;2(2):122-130. doi: 10.15326/jcopdf.2.2.2014.0155.

35.

Noninvasive ventilation improves sleep in amyotrophic lateral sclerosis: a prospective polysomnographic study.

Vrijsen B, Buyse B, Belge C, Robberecht W, Van Damme P, Decramer M, Testelmans D.

J Clin Sleep Med. 2015 Apr 15;11(5):559-66. doi: 10.5664/jcsm.4704.

36.

Effects of controlled mechanical ventilation on sepsis-induced diaphragm dysfunction in rats.

Maes K, Stamiris A, Thomas D, Cielen N, Smuder A, Powers SK, Leite FS, Hermans G, Decramer M, Hussain SN, Gayan-Ramirez G.

Crit Care Med. 2014 Dec;42(12):e772-82. doi: 10.1097/CCM.0000000000000685.

PMID:
25402297
37.

Modelling the dynamics of expiratory airflow to describe chronic obstructive pulmonary disease.

Topalovic M, Exadaktylos V, Decramer M, Troosters T, Berckmans D, Janssens W.

Med Biol Eng Comput. 2014 Dec;52(12):997-1006. doi: 10.1007/s11517-014-1202-6. Epub 2014 Sep 30.

PMID:
25266260
38.

Prevention of Exacerbations in Chronic Obstructive Pulmonary Disease: Knowns and Unknowns.

Agustí A, Calverley PM, Decramer M, Stockley RA, Wedzicha JA.

Chronic Obstr Pulm Dis. 2014 Sep 25;1(2):166-184. doi: 10.15326/jcopdf.1.2.2014.0134. Review.

39.

Withdrawal of inhaled glucocorticoids and exacerbations of COPD.

Magnussen H, Disse B, Rodriguez-Roisin R, Kirsten A, Watz H, Tetzlaff K, Towse L, Finnigan H, Dahl R, Decramer M, Chanez P, Wouters EF, Calverley PM; WISDOM Investigators.

N Engl J Med. 2014 Oct 2;371(14):1285-94. doi: 10.1056/NEJMoa1407154. Epub 2014 Sep 8.

40.

Acute bronchodilator responses decline progressively over 4 years in patients with moderate to very severe COPD.

Tashkin DP, Li N, Kleerup EC, Halpin D, Celli B, Decramer M, Elashoff R.

Respir Res. 2014 Aug 31;15:102. doi: 10.1186/s12931-014-0102-5.

41.

Tiotropium might improve survival in subjects with COPD at high risk of mortality.

Burgel PR, Paillasseur JL, Dusser D, Roche N, Liu D, Liu Y, Furtwaengler A, Metzdorf N, Decramer M; UPLIFT® Study Investigators.

Respir Res. 2014 Jun 10;15:64. doi: 10.1186/1465-9921-15-64.

42.

Preventing COPD exacerbations with macrolides: a review and budget impact analysis--author response to letter to the editor.

Simoens S, Laekeman G, Decramer M.

Respir Med. 2014 Jul;108(7):1065. doi: 10.1016/j.rmed.2014.04.013. Epub 2014 May 6. No abstract available.

43.

Tiotropium in patients with moderate COPD naive to maintenance therapy: a randomised placebo-controlled trial.

Troosters T, Sciurba FC, Decramer M, Siafakas NM, Klioze SS, Sutradhar SC, Weisman IM, Yunis C.

NPJ Prim Care Respir Med. 2014 May 20;24:14003. doi: 10.1038/npjpcrm.2014.3.

44.

Efficacy and safety of umeclidinium plus vilanterol versus tiotropium, vilanterol, or umeclidinium monotherapies over 24 weeks in patients with chronic obstructive pulmonary disease: results from two multicentre, blinded, randomised controlled trials.

Decramer M, Anzueto A, Kerwin E, Kaelin T, Richard N, Crater G, Tabberer M, Harris S, Church A.

Lancet Respir Med. 2014 Jun;2(6):472-86. doi: 10.1016/S2213-2600(14)70065-7. Epub 2014 May 14.

PMID:
24835833
45.

An official American Thoracic Society/European Respiratory Society statement: update on limb muscle dysfunction in chronic obstructive pulmonary disease.

Maltais F, Decramer M, Casaburi R, Barreiro E, Burelle Y, Debigaré R, Dekhuijzen PN, Franssen F, Gayan-Ramirez G, Gea J, Gosker HR, Gosselink R, Hayot M, Hussain SN, Janssens W, Polkey MI, Roca J, Saey D, Schols AM, Spruit MA, Steiner M, Taivassalo T, Troosters T, Vogiatzis I, Wagner PD; ATS/ERS Ad Hoc Committee on Limb Muscle Dysfunction in COPD.

Am J Respir Crit Care Med. 2014 May 1;189(9):e15-62. doi: 10.1164/rccm.201402-0373ST. Review.

46.

Acute lung allograft rejection: diagnostic role of probe-based confocal laser endomicroscopy of the respiratory tract.

Yserbyt J, Dooms C, Decramer M, Verleden GM.

J Heart Lung Transplant. 2014 May;33(5):492-8. doi: 10.1016/j.healun.2014.01.857. Epub 2014 Jan 24.

PMID:
24656287
47.

Standardizing the analysis of physical activity in patients with COPD following a pulmonary rehabilitation program.

Demeyer H, Burtin C, Van Remoortel H, Hornikx M, Langer D, Decramer M, Gosselink R, Janssens W, Troosters T.

Chest. 2014 Aug;146(2):318-327. doi: 10.1378/chest.13-1968.

48.

COPD awareness survey: do Belgian pulmonary physicians comply with the GOLD guidelines 2010?

Decramer M, Brusselle G, Buffels J, Corhay JL, De Backer W, Degryse JM, Janssens W, Marchand E, Van den Brande P, Vincken W, Gayan-Ramirez G, Van Craenendonck V, Vandenberghe H, De Vuyst P; COPD Working Group.

Acta Clin Belg. 2013 Sep-Oct;68(5):325-40.

PMID:
24579239
49.

Impaired postural control reduces sit-to-stand-to-sit performance in individuals with chronic obstructive pulmonary disease.

Janssens L, Brumagne S, McConnell AK, Claeys K, Pijnenburg M, Goossens N, Burtin C, Janssens W, Decramer M, Troosters T.

PLoS One. 2014 Feb 12;9(2):e88247. doi: 10.1371/journal.pone.0088247. eCollection 2014.

50.

The influence of comorbidities on outcomes of pulmonary rehabilitation programs in patients with COPD: a systematic review.

Hornikx M, Van Remoortel H, Demeyer H, Marcal Camillo CA, Decramer M, Janssens W, Troosters T.

Biomed Res Int. 2013;2013:146148. doi: 10.1155/2013/146148. Epub 2013 Dec 26. Review.

Supplemental Content

Loading ...
Support Center